Innsbruck, Austria

Kenneth Mugridge

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Med-El Elektromedizinische Geraete Gmbh. Active years: 2017.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Mugridge: Innovator in Implantable Drug Delivery Systems

Introduction

Kenneth Mugridge is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of medical technology, particularly in the development of implantable drug delivery systems. His innovative work has the potential to improve patient care and treatment outcomes.

Latest Patents

Kenneth Mugridge holds a patent for an "Implantable fluid delivery apparatus and implantable electrode." This implantable drug delivery system features a middle ear section that is fixed to the tympanic membrane of a patient. The system is designed to deliver pharmaceutical agents directly into the inner ear, enhancing the effectiveness of treatments for various conditions.

Career Highlights

Mugridge's career is marked by his dedication to advancing medical technology. He works at Med-El Elektromedizinische Geräte GmbH, a company known for its innovative solutions in the field of hearing and implantable medical devices. His work has led to the development of groundbreaking technologies that address complex medical challenges.

Collaborations

Throughout his career, Kenneth Mugridge has collaborated with esteemed colleagues such as Claude Jolly and Ingeborg Hochmair. These partnerships have fostered an environment of innovation and have contributed to the success of various projects in the medical technology sector.

Conclusion

Kenneth Mugridge's contributions to implantable drug delivery systems exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements that can significantly enhance patient treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…